SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Raymed Labs - Quaterly Results

02 Aug 2023 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended June 2023, as compared to corresponding quarter of last year.The Net Loss for the quarter ended June 2023 is Rs. -0.16 millions as compared to Net Loss of Rs. -0.51 millions of corresponding quarter ended June 2022 Operating profit Margin for the quarter ended June 2023 improved to -0.15% as compared to -0.50% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.21 0.00 0.00
PBIDT -0.15 -0.50 -70.00 -0.15 -0.50 -70.00 -1.65 -0.77 114.29
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.15 -0.50 -70.00 -0.15 -0.50 -70.00 -1.65 -0.77 114.29
Depreciation 0.01 0.01 0.00 0.01 0.01 0.00 0.06 0.05 20.00
PBT -0.16 -0.51 -68.63 -0.16 -0.51 -68.63 -1.71 -0.82 108.54
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.16 -0.51 -68.63 -0.16 -0.51 -68.63 -1.71 -0.82 108.54
Equity 42.74 42.74 0.00 42.74 42.74 0.00 42.74 42.74 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Cresanto Global Share Price

4.65 0.00 (0.00%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×